Table 1. The half maximal inhibition concentration (IC50) values of niclosamide in some tumor cell lines and normal cells.
Tumor type | Cell line | IC50 (µmol/L) | Reference |
Leukemia | |||
Acute myeloid leukemia | U937 | 0.41 | [2] |
OCI-AML3 | 0.79 | [2] | |
HL-60 | 0.48 | [2] | |
Molm13 | 0.72 | [2] | |
MV4-11 | 1.0 | [2] | |
Solid tumor | |||
Prostrate cancer | Du145 | 0.7 | [5] |
PC3 | 11.7±2.3 | [5] | |
Colorectal cancer | HT29 | 7.2±1.2 | [5] |
HCT116 | 2.2 | [4] | |
Cervical carcinoma | HeLa | 0.25±0.07 | [5] |
Lung adenocarcinoma | A549 | 3.0±0.2 | [5] |
Epithelial carcinoma | A431 | 8.8±0.9 | [5] |
Normal cell | |||
MEF | 4.54 | [2] | |
NHFB | 5.78 | [2] | |
Bone marrow | 9.00±4.87 | [2] |